Commitments and Contingencies - Part-1 (Details) - USD ($) |
Feb. 21, 2025 |
Jan. 30, 2025 |
Jun. 30, 2024 |
May 03, 2023 |
Oct. 05, 2021 |
Sep. 01, 2021 |
Jun. 30, 2025 |
|---|---|---|---|---|---|---|---|
| Commitments and Contingencies [Line Items] | |||||||
| Compensatory damages in excess | $ 11,286,570 | ||||||
| Payment of full amount of fees total | $ 714,557 | ||||||
| Commitments combined amount | $ 50,000 | ||||||
| Defendants amount | $ 81,720 | ||||||
| Cancellation of shares (in Shares) | 2,385 | 2,385 | |||||
| Loan amount | $ 130,000 | ||||||
| Dr. Krauss’s Resignation Agreement [Member] | Promissory Note [Member] | |||||||
| Commitments and Contingencies [Line Items] | |||||||
| Principal amount | $ 371,178 | ||||||
| Additional amount | $ 300,000 | ||||||
| Settlement Agreement [Member] | |||||||
| Commitments and Contingencies [Line Items] | |||||||
| Settlement payment | $ 50,000 | ||||||
| Restricted common stock (in Shares) | 200,000 | ||||||
| Restricted common stock | $ 250,000 | ||||||
| Accrued interest | $ 25,171 | ||||||
| Action Against Tyche Capital LLC [Member] | |||||||
| Commitments and Contingencies [Line Items] | |||||||
| Interest accruing | $ 6,776,686 |
| X | ||||||||||
- Definition The amount of aggregate loan amount. No definition available.
|
| X | ||||||||||
- Definition The amount of debt additional amount. No definition available.
|
| X | ||||||||||
- Definition The amount of loss contingency of defendants. No definition available.
|
| X | ||||||||||
- Definition The amount of payments of full amount of fees totaling. No definition available.
|
| X | ||||||||||
- Definition Amount of principal of debt issued. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accrued but unpaid interest on deposit liabilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of fee payable for management of operations based on performance under arrangement, including, but not limited to, investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Best estimate of the reasonably possible loss exposure in excess of the amount accrued for damages pertaining to a specified product. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares (or other type of equity) forfeited during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate value of stock related to Restricted Stock Awards issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|